Home LiteratureArticle Details
PMID: 21992749 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease.

NeuroImage ·Vol. 59 ·No. 2 ·2012-01-16 ·Pages 895-907

Zhang D, Shen D, Alzheimer's Disease Neuroimaging Initiative

Abstract

Many machine learning and pattern classification methods have been applied to the diagnosis of Alzheimer's disease (AD) and its prodromal stage, i.e., mild cognitive impairment (MCI). Recently, rather than predicting categorical variables as in classification, several pattern regression methods have also been used to estimate continuous clinical variables from brain images. However, most existing regression methods focus on estimating multiple clinical variables separately and thus cannot utilize the intrinsic useful correlation information among different clinical variables. On the other hand, in those regression methods, only a single modality of data (usually only the structural MRI) is often used, without considering the complementary information that can be provided by different modalities. In this paper, we propose a general methodology, namely multi-modal multi-task (M3T) learning, to jointly predict multiple variables from multi-modal data. Here, the variables include not only the clinical variables used for regression but also the categorical variable used for classification, with different tasks corresponding to prediction of different variables. Specifically, our method contains two key components, i.e., (1) a multi-task feature selection which selects the common subset of relevant features for multiple variables from each modality, and (2) a multi-modal support vector machine which fuses the above-selected features from all modalities to predict multiple (regression and classification) variables. To validate our method, we perform two sets of experiments on ADNI baseline MRI, FDG-PET, and cerebrospinal fluid (CSF) data from 45 AD patients, 91 MCI patients, and 50 healthy controls (HC). In the first set of experiments, we estimate two clinical variables such as Mini Mental State Examination (MMSE) and Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), as well as one categorical variable (with value of 'AD', 'MCI' or 'HC'), from the baseline MRI, FDG-PET, and CSF data. In the second set of experiments, we predict the 2-year changes of MMSE and ADAS-Cog scores and also the conversion of MCI to AD from the baseline MRI, FDG-PET, and CSF data. The results on both sets of experiments demonstrate that our proposed M3T learning scheme can achieve better performance on both regression and classification tasks than the conventional learning methods.

MeSH Terms
Aged Aged, 80 and over Algorithms Alzheimer Disease/diagnosis Artificial Intelligence Female Humans Image Interpretation, Computer-Assisted/methods Male Middle Aged Neuroimaging/methods Pattern Recognition, Automated/methods Regression Analysis Reproducibility of Results Sensitivity and Specificity Subtraction Technique
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zhang Daoqiang
Department of Radiology and BRIC, University of North Carolina at Chapel Hill, NC 27599, USA. [email protected]
Shen Dinggang
Alzheimer's Disease Neuroimaging Initiative
References (44)
44 references, click to expand
  1. HAMMER: hierarchical attribute matching mechanism for elastic registration.
    IEEE Trans Med Imaging. 2002 Nov;21(11):1421-39 PMID: 12575879
  2. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
    J Psychiatr Res. 1975 Nov;12(3):189-98 PMID: 1202204
  3. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Brain. 2007 Apr;130(Pt 4):1159-66 PMID: 17353226
  4. A nonparametric method for automatic correction of intensity nonuniformity in MRI data.
    IEEE Trans Med Imaging. 1998 Feb;17(1):87-97 PMID: 9617910
  5. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease.
    Neurobiol Aging. 2000 Jan-Feb;21(1):19-26 PMID: 10794844
  6. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
    Brain. 2007 Oct;130(Pt 10):2616-35 PMID: 17704526
  7. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.
    Neurobiol Aging. 2010 Aug;31(8):1284-303 PMID: 20538372
  8. Forecasting the global burden of Alzheimer's disease.
    Alzheimers Dement. 2007 Jul;3(3):186-91 PMID: 19595937
  9. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
    Neurocase. 2005 Feb;11(1):14-25 PMID: 15804920
  10. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
    Neurology. 2009 Jul 28;73(4):294-301 PMID: 19636049
  11. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.
    Neurobiol Aging. 2007 Jul;28(7):1070-4 PMID: 16782233
  12. Increasing power to predict mild cognitive impairment conversion to Alzheimer's disease using hippocampal atrophy rate and statistical shape models.
    Med Image Comput Comput Assist Interv. 2010;13(Pt 2):125-32 PMID: 20879307
  13. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.
    Radiology. 2009 Apr;251(1):195-205 PMID: 19201945
  14. Predicting clinical scores from magnetic resonance scans in Alzheimer's disease.
    Neuroimage. 2010 Jul 15;51(4):1405-13 PMID: 20347044
  15. A fast diffeomorphic image registration algorithm.
    Neuroimage. 2007 Oct 15;38(1):95-113 PMID: 17761438
  16. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.
    J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7 PMID: 11909909
  17. Magnetic resonance image tissue classification using a partial volume model.
    Neuroimage. 2001 May;13(5):856-76 PMID: 11304082
  18. Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.
    J Neurol. 2007 Dec;254(12):1666-75 PMID: 17994313
  19. Hippocampal formation glucose metabolism and volume losses in MCI and AD.
    Neurobiol Aging. 2001 Jul-Aug;22(4):529-39 PMID: 11445252
  20. Relating one-year cognitive change in mild cognitive impairment to baseline MRI features.
    Neuroimage. 2009 Oct 1;47(4):1363-70 PMID: 19371783
  21. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.
    IEEE Trans Med Imaging. 2001 Jan;20(1):45-57 PMID: 11293691
  22. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
    Ann Neurol. 2009 Apr;65(4):403-13 PMID: 19296504
  23. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.
    J Neurosci. 2010 Feb 10;30(6):2088-101 PMID: 20147537
  24. Comparing predictors of conversion and decline in mild cognitive impairment.
    Neurology. 2010 Jul 20;75(3):230-8 PMID: 20592257
  25. Fast robust automated brain extraction.
    Hum Brain Mapp. 2002 Nov;17(3):143-55 PMID: 12391568
  26. Multi-modal imaging predicts memory performance in normal aging and cognitive decline.
    Neurobiol Aging. 2010 Jul;31(7):1107-21 PMID: 18838195
  27. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
    JAMA. 2009 Jul 22;302(4):385-93 PMID: 19622817
  28. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.
    AJNR Am J Neuroradiol. 2010 Feb;31(2):347-54 PMID: 20075088
  29. Multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Neuroimage. 2011 Apr 1;55(3):856-67 PMID: 21236349
  30. Predicting clinical variable from MRI features: application to MMSE in MCI.
    Med Image Comput Comput Assist Interv. 2005;8(Pt 1):392-9 PMID: 16685870
  31. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Neuroimage. 2009 Feb 15;44(4):1415-22 PMID: 19027862
  32. A new rating scale for Alzheimer's disease.
    Am J Psychiatry. 1984 Nov;141(11):1356-64 PMID: 6496779
  33. Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: exploring the influence of various parameters.
    Neuroimage. 2010 Apr 15;50(3):883-92 PMID: 20070949
  34. Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study.
    Neuroimage. 2008 Jun;41(2):277-85 PMID: 18400519
  35. Imaging cerebral atrophy: normal ageing to Alzheimer's disease.
    Lancet. 2004 Jan 31;363(9406):392-4 PMID: 15074306
  36. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
    Neurology. 1999 Apr 22;52(7):1397-403 PMID: 10227624
  37. High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables.
    Neuroimage. 2010 May 1;50(4):1519-35 PMID: 20056158
  38. Mild cognitive impairment represents early-stage Alzheimer disease.
    Arch Neurol. 2001 Mar;58(3):397-405 PMID: 11255443
  39. Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.
    Neuroimage. 2011 Mar 15;55(2):574-89 PMID: 21146621
  40. Longitudinal changes of CSF biomarkers in memory clinic patients.
    Neurology. 2007 Sep 4;69(10):1006-11 PMID: 17785669
  41. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.
    Neurobiol Aging. 2011 Dec;32(12):2322.e19-27 PMID: 20594615
  42. FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.
    Psychiatry Res. 2007 Jul 15;155(2):167-71 PMID: 17531450
  43. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.
    J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1219-22 PMID: 16891386
  44. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment.
    Neuroreport. 2002 Oct 28;13(15):1939-43 PMID: 12395096
Article Info
Journal
NeuroImage
Abbr.
Neuroimage
ISSN
1095-9572
Published
2012-01-16
Epub
2011-00-04
Pages
895-907
Language
English
Region
United States
NLM ID
9215515
PMCID
PMC3230721
Subset
IM
Grants
NIBIB NIH HHS · R01 EB008374 · United States
NIBIB NIH HHS · R01 EB006733 · United States
NIMH NIH HHS · RC1 MH088520-01 · United States
NIMH NIH HHS · MH088520 · United States
NIBIB NIH HHS · EB009634 · United States
NIBIB NIH HHS · EB006733 · United States
NIBIB NIH HHS · R01 EB008374-01A2 · United States
NIBIB NIH HHS · EB008374 · United States
NIA NIH HHS · U01 AG024904 · United States
NIA NIH HHS · U19 AG010483 · United States
NIBIB NIH HHS · R01 EB009634 · United States
NIBIB NIH HHS · R01 EB009634-01A1 · United States
NIMH NIH HHS · RC1 MH088520 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]